PL377856A1 - Identyfikacja trimerów N-alkiloglicyny dla wywoływania apoptozy - Google Patents

Identyfikacja trimerów N-alkiloglicyny dla wywoływania apoptozy

Info

Publication number
PL377856A1
PL377856A1 PL377856A PL37785604A PL377856A1 PL 377856 A1 PL377856 A1 PL 377856A1 PL 377856 A PL377856 A PL 377856A PL 37785604 A PL37785604 A PL 37785604A PL 377856 A1 PL377856 A1 PL 377856A1
Authority
PL
Poland
Prior art keywords
apoptosis
induction
identification
alkylglycine trimers
alkylglycine
Prior art date
Application number
PL377856A
Other languages
English (en)
Inventor
Gema Tarrason
Claudia Cases
Jaume Piulats
Angel Messeguer
Nuria Cortes
Isabel Masip
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL377856A1 publication Critical patent/PL377856A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Epoxy Compounds (AREA)
PL377856A 2003-04-15 2004-04-08 Identyfikacja trimerów N-alkiloglicyny dla wywoływania apoptozy PL377856A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03008604 2003-04-15

Publications (1)

Publication Number Publication Date
PL377856A1 true PL377856A1 (pl) 2006-02-20

Family

ID=33185843

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377856A PL377856A1 (pl) 2003-04-15 2004-04-08 Identyfikacja trimerów N-alkiloglicyny dla wywoływania apoptozy

Country Status (12)

Country Link
US (1) US20060229255A1 (pl)
EP (1) EP1723165A1 (pl)
JP (1) JP2007524587A (pl)
KR (1) KR20050123162A (pl)
CN (1) CN1774446A (pl)
AU (1) AU2004230207A1 (pl)
BR (1) BRPI0409470A (pl)
CA (1) CA2522203A1 (pl)
MX (1) MXPA05010931A (pl)
PL (1) PL377856A1 (pl)
WO (1) WO2004092204A1 (pl)
ZA (1) ZA200509182B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008127298A2 (en) * 2006-10-24 2008-10-23 Subroto Chatterjee Staphylococcal enterotoxin b peptide compositions and methods of use
US8479107B2 (en) * 2009-12-31 2013-07-02 Nokia Corporation Method and apparatus for fluid graphical user interface
AU2016338410B2 (en) 2015-10-14 2021-07-15 X-Therma, Inc. Compositions and methods for reducing ice crystal formation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747458A (en) * 1995-06-07 1998-05-05 Chiron Corporation Urokinase receptor ligands
ES2169690B1 (es) * 2000-10-06 2004-03-16 Diverdrugs Sl Trimeros de n-alquilglicina capaces de proteger a neuronas contra agresiones excitotoxicas, y composiciones que los contienen.
ES2169691B1 (es) * 2000-10-11 2004-03-16 Diverdrugs Sl Trimeros de n-alquilglicina capaces de bloquear la respuesta a sustancias quimicas, estimulos termicos o mediadores de la inflamacion de receptores neuronales, y composiciones que los contienen.

Also Published As

Publication number Publication date
CA2522203A1 (en) 2004-10-28
WO2004092204A1 (en) 2004-10-28
AU2004230207A1 (en) 2004-10-28
KR20050123162A (ko) 2005-12-29
ZA200509182B (en) 2007-04-25
EP1723165A1 (en) 2006-11-22
BRPI0409470A (pt) 2006-05-02
MXPA05010931A (es) 2005-11-25
JP2007524587A (ja) 2007-08-30
CN1774446A (zh) 2006-05-17
US20060229255A1 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
GB0403041D0 (en) Induction of apoptosis
HK1089636A1 (en) Positive patient identification
HK1093483A1 (en) Polymorphic form of n-
HK1083443A1 (en) Thiazolidin-4-ones for inhibiting hyak3 proteins
PL370909A1 (pl) Cis-imidazoliny jako inhibitory MDM2
GB2393760B (en) Induction system
AU2003300020A8 (en) Modulation of pten expression via oligomeric compounds
IL179811A0 (en) Identification of tumors
PL2574741T3 (pl) Układ do udoskonalonego wykorzystania ciepła
GB0303195D0 (en) Cooling system
GB0326491D0 (en) Cooling of liquids
GB0420567D0 (en) Frequency controlled lighting system
AP1947A (en) Masked identification means
PL377856A1 (pl) Identyfikacja trimerów N-alkiloglicyny dla wywoływania apoptozy
EP1605893A4 (en) TRANS-MEMBRANE ANTIBODY-INDUCED APOPTOSIS INHIBITION
GB0314803D0 (en) Improved cooling system
GB0327966D0 (en) Cooling system
IL171945A0 (en) Iodopyrazolyl carboxanilides
PL375437A1 (pl) Synteza gatifloksacyny
GB0318913D0 (en) Apoptosis inhibitors
TW579003U (en) Cooling system
GB2404167B (en) Identification plates
GB0305085D0 (en) Identification band
IL166132A0 (en) Method for the identification of ligands
GB0310501D0 (en) Polyphenol

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)